{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:47:38Z","timestamp":1648990058346},"reference-count":26,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1179\/joc.1999.11.2.144","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:05:01Z","timestamp":1389290701000},"page":"144-149","source":"Crossref","is-referenced-by-count":3,"title":["Second-Line Chemotherapy with Cisplatin-Ifosfamide in Patients with Ovarian Cancer Previously Treated with Carboplatin-Cyclophosphamide"],"prefix":"10.1080","volume":"11","author":[{"given":"A.","family":"Polyzos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tsavaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kosmas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Petrikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Giannikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kalahanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Giannakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Veslemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Katsilambros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-2-165"},{"key":"CIT0002","first-page":"1157","volume":"5","author":"Neijt JP","year":"1987","journal-title":"CHAP-5 v CP) in advanced ovarian carcinoma. J Clin Oncol"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.1989.7.4.457","volume":"7","author":"Omura GA","year":"1989","journal-title":"J Clin Oncol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.1986.4.11.1579","volume":"4","author":"Louie KG","year":"1986","journal-title":"J Clin Oncol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-4-273"},{"key":"CIT0006","first-page":"214","volume":"27","author":"Surwit EA","year":"1987","journal-title":"Phase II trial of vinblastine in previously treated patients with ovarian cancer: A Southwest Oncology Group study. Gynecol Oncol"},{"key":"CIT0007","first-page":"277","volume":"71","author":"Pater JL","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(87)90298-8"},{"key":"CIT0009","first-page":"335","volume":"71","author":"Osborne RJ","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901015)60:8+<2104::AID-CNCR2820601524>3.0.CO;2-D"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1989.7.11.1672","volume":"7","author":"Sutton GP","year":"1989","journal-title":"J Clin Oncol"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","volume":"9","author":"Markman M","year":"1991","journal-title":"J Clin Oncol"},{"key":"CIT0014","first-page":"243","volume":"10","author":"Markman M","year":"1992","journal-title":"Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer. Activity in platinum-resistant disease. J Clin Oncol"},{"key":"CIT0015","first-page":"14","volume":"9","author":"Goldin A","year":"1982","journal-title":"Semin Oncol"},{"key":"CIT0016","first-page":"274","volume":"36","author":"Tenfel G","year":"1976","journal-title":"Geburts Franen Heilk"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"CIT0019","unstructured":"Dixon WS, Massey FJJr. Introduction to statistical analysis. 4th edition, New York, McGraw-Hill, 1983."},{"key":"CIT0020","first-page":"29","volume":"14","author":"Bruhl P","year":"1976","journal-title":"Int Clin Pharmacol"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.1012"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(89)80039-3"},{"key":"CIT0023","first-page":"419","volume":"7","author":"Marzola M","year":"1996","journal-title":"Salvage therapy with ifosfamide and mitoxantrone in advance ovarian cancer. Ann Oncol"},{"key":"CIT0026","first-page":"301","volume":"15","author":"Pucci F","year":"1996","journal-title":"Paclitaxel and ifos-famide in heavily pretreated patients with advanced ovarian cancer. Proc ASCO"},{"key":"CIT0027","first-page":"295","volume":"15","author":"Klaassen U","year":"1996","journal-title":"Paclitaxel and ifosfamide in pretreated patients with advanced ovarian carcinoma. Proc ASCO"},{"key":"CIT0028","first-page":"195","volume":"8","author":"Dimopoulos MA","year":"1997","journal-title":"Ifosfamide and paclitaxel chemotherapy for advanced epithelial ovarian cancer. Ann Oncol"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1200\/JCO.1997.15.10.3208","volume":"15","author":"De Lena M","year":"1997","journal-title":"J Clin Oncol"},{"key":"CIT0030","first-page":"1748","volume":"12","author":"Trigpen JT","year":"1994","journal-title":"Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: A Gynecologic Oncology Group Study. J Clin Oncol"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T04:43:57Z","timestamp":1565066637000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.1999.11.2.144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1179\/joc.1999.11.2.144"],"URL":"https:\/\/doi.org\/10.1179\/joc.1999.11.2.144","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}